-20C, 1 month (sealed storage, away from moisture) Purity & Documentation Data Sheet (268 KB) SDS (252 KB) English - EN (252 KB) Franais - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Espaol - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB) Handling Instructions (2659 KB) References Calculators Concentration (start) Volume (start) = Concentration (final) Volume (final)
Recalls & Warnings June 20, 2003 FTC Charges Marketers of Seasilver with False and Deceptive Claims On June 19, 2003, The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) announced coordinated actions against two companies - both charged with promoting the dietary supplement "Seasilver" with unsubstantiated medical claims
Too toxic to ignore
Julian Douwes, M.D
Adverse effects vary by molecule, dose, and patient sensitivity
For a complete list of potential side effects, visit the drug manufacturer websites for: Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide), the three GLP-1 medications that are FDA-approved for overweight and obesity